PROTAC Library

Loading...
E3 Ligase
Target
Molecular Weight
to
Your selection
  • Your selection
Structure Catalog Product Name CAS E3 Ligase Target Inquiry
N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)hexanamide BPL-200973 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)hexanamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 853.91

Molecular Formula: C43H41F2N7O8S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-3-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)propanamide BPL-200974 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-3-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)propanamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 855.88

Molecular Formula: C42H39F2N7O9S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-7-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)heptanamide BPL-200975 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-7-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)heptanamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 867.93

Molecular Formula: C44H43F2N7O8S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)octanamide BPL-200976 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)octanamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 881.96

Molecular Formula: C45H45F2N7O8S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-3-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)propanamide BPL-200977 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-3-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)propanamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 899.93

Molecular Formula: C44H43F2N7O10S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-3-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethoxy)propanamide BPL-200978 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-3-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethoxy)propanamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 943.98

Molecular Formula: C46H47F2N7O11S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)-3,6,9,12-tetraoxapentadecan-15-amide BPL-200979 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)-3,6,9,12-tetraoxapentadecan-15-amide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 988.04

Molecular Formula: C48H51F2N7O12S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)-3,6,9,12,15-pentaoxaoctadecan-18-amide BPL-200980 N-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)-3,6,9,12,15-pentaoxaoctadecan-18-amide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 1032.09

Molecular Formula: C50H55F2N7O13S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(3-(5-((1-(4-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide BPL-200981 N-(3-(5-((1-(4-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 882.95

Molecular Formula: C43H44F2N10O7S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(3-(5-((1-(5-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide BPL-200982 N-(3-(5-((1-(5-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 896.98

Molecular Formula: C44H46F2N10O7S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(3-(5-((1-(6-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide BPL-200983 N-(3-(5-((1-(6-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 911.01

Molecular Formula: C45H48F2N10O7S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(3-(5-((1-(3-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)propanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide BPL-200984 N-(3-(5-((1-(3-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)propanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 912.98

Molecular Formula: C44H46F2N10O8S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(3-(5-((1-(7-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)heptanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide BPL-200985 N-(3-(5-((1-(7-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)heptanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 925.03

Molecular Formula: C46H50F2N10O7S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(3-(5-((1-(8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide BPL-200986 N-(3-(5-((1-(8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 939.06

Molecular Formula: C47H52F2N10O7S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N-(3-(5-((1-(3-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)propanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide BPL-200987 N-(3-(5-((1-(3-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)propanoyl)piperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide

CRBN

BRAF V600E

Inquiry

Molecular Weight: 957.03

Molecular Formula: C46H50F2N10O9S

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

P4B BPL-200988 P4B 2485722-76-5

CRBN

BRAF V600E

Inquiry

Molecular Weight: 1045.14

Molecular Formula: C50H58F2N10O11S

Density: 1.46±0.1 g/cm3

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

P5B BPL-200989 P5B 2485722-77-6

CRBN

BRAF V600E

Inquiry

Molecular Weight: 1089.19

Molecular Formula: C52H62F2N10O12S

Density: 1.44±0.1 g/cm3

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N1-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-N5-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)glutaramide BPL-200990 N1-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-N5-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)glutaramide

VHL

BRAF V600E

Inquiry

Molecular Weight: 1011.19

Molecular Formula: C51H56F2N8O8S2

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

N1-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-N6-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)adipamide BPL-200991 N1-(4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)-N6-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)adipamide

VHL

BRAF V600E

Inquiry

Molecular Weight: 1025.21

Molecular Formula: C52H58F2N8O8S2

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

(2S,4R)-1-((S)-2-(3-(3-((4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)amino)-3-oxopropoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide BPL-200992 (2S,4R)-1-((S)-2-(3-(3-((4-(3-(2,6-Difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzyl)amino)-3-oxopropoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

VHL

BRAF V600E

Inquiry

Molecular Weight: 1041.21

Molecular Formula: C52H58F2N8O9S2

Description: It is a thalidomide-based heterobifunctional PROTAC that induces selective degradation of BRAF-V600E, but not the wild-type BRAF.

We invite you to contact us at protac@bocsci.com or through our contact form above for more information about our services and products.

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: protac@bocsci.com
  • Fax: 1-631-614-7828
UK
Inquiry Basket

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x